4-BUTYLRESORCINOL

CCCCC1=CC=C(O)C=C1O

InChIKey=CSHZYWUPJWVTMQ-UHFFFAOYSA-N

InChI=1S/C10H14O2/c1-2-3-4-8-5-6-9(11)7-10(8)12/h5-7,11-12H,2-4H2,1H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Targets

Primary Target	Pharmacology	Condition	Potency
Tyrosinase 41 Target ID: CHEMBL1973 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23205541	Inhibitor 8504		21.0 µM [IC50]

PubMed

Title	Date	PubMed
Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders.	2010-06-18	20640168
Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: a randomized controlled split-face trial.	2010-04	20507399
The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial.	2010-02	20548876
Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety.	2009-03-01	19181523
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.	2007-05	17388924
Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.	2005-12	16327152

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:34:17 GMT 2025` Edited by `admin` on `Mon Mar 31 19:34:17 GMT 2025`
Record UNII	2IK4UQ3ZGA
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

RUCINOL

Preferred Name

English

4-BUTYLRESORCINOL

Official Name

English

RESORCINOL, 4-BUTYL-

Systematic Name

English

4-n-butylresorcinol [WHO-DD]

Common Name

English

VIVINOL

Brand Name

English

1,3-BENZENEDIOL, 4-BUTYL-

Systematic Name

English

Code System Code Type Description

DAILYMED

2IK4UQ3ZGA